gfap
Table of Contents
autoimmune glial fibrillary acid protein astrocytopathy / GFAP astrocytopathy
see also:
Introduction
- a rare form of autoimmune encephalitis associated with IgG autoantibodies that target GFAP in astrocytes, which leads to an eventual loss of astrocytes
- first described by Boyan Fang, Vanda Lennon, and colleagues from the Mayo Clinic in their 2016 seminal paper
Epidemiology
- rare
Aetiology
- the autoantibodies may have a paraneoplastic or parainfectious aetiological basis
- 1/3rd of cases are associated with an ovarian teratoma or an adenocarcinoma
Clinical features
- broad spectrum of clinical features but usually consistent with meningo-encephalitis clinical features
Diagnosis
-
- usually elevated protein levels, pleocytosis and positive for GFAP antibodies
- co-existing autoantibodies (e.g. NMDAR antibody, AQP4 antibody) may also be present especially in patients with ovarian teratoma 1)
- MRI brain:
- T2/FLAIR
- up to 75% have hyperintense, diffuse, confluent, periventricular white matter lesions
DDx
- a range of other differentials of the MRI findings - see https://radiopaedia.org/articles/autoimmune-glial-fibrillary-acid-protein-gfap-astrocytopathy
Rx
- high dose IV steroids
gfap.txt · Last modified: 2026/09/02 05:38 by wh